SAN BERNARDINO COUNTY, CA / ACCESS Newswire / June 16, 2025 / Dateline Resources Limited (ASX:DTR)(OTC:DTREF), a leading Australian mining and exploration company, is pleased to announce the start of a comprehensive exploration program at its wholly owned Colosseum Gold and Rare Earth Elements (REE) Project in San Bernardino County, California. This strategic initiative highlights Dateline’s dedication to unlocking the full potential of this high-value asset, located in the mineral-rich Walker Lane Trend.
The exploration program includes a 1,207-sample geochemical survey, now underway, targeting high-priority zones such as newly identified felsite dykes west of historic pits and untested gravity-low anomalies to the east. Samples will undergo multi-element analysis, including a full suite of rare earth elements, to identify gold and REE mineralization potential. Initial results are expected in early July 2025, with a comprehensive analysis to follow.
In parallel, a magneto telluric (MT) survey is mobilizing to map deep subsurface geological structures and alteration zones across the Colosseum claim boundary, with a progress update expected later this week. Dateline is also evaluating a ground-based magnetic survey to enhance its multi-dataset approach, aiding in the detection of buried intrusions and lithological contrasts to refine drill targets.
The Colosseum Project is central to Dateline’s North American strategy, with a JORC-2012 compliant Mineral Resource Estimate of 27.1 million tonnes at 1.26 g/t gold for 1.1 million ounces, with over 67% in Measured and Indicated categories. The project’s gold mineralization remains open at depth, and recent studies project an NPV of $550 million and an IRR of 61% at a gold price of $2,900 per ounce (ASX announcement, May 23, 2025). Located just 10 kilometers north of the world-class Mountain Pass REE mine, Colosseum also holds significant rare earth potential. With growing global demand for critical minerals and robust U.S. government support for domestic REE production, Dateline aims to contribute to America’s strategic mineral supply chain.
Managing Director Stephen Baghdadi commented: “The last time this mine was in operation, the gold price was under $350 per ounce and there was little incentive to do follow-up exploration work for hidden breccia pipes. During that period, rare earth elements (REEs) were not yet a focus, so the significant REE findings at Colosseum has only recently become important. We are now in a very different environment, with much higher gold prices and strong strategic demand for REEs, which makes our systematic field program at Colosseum essential.”
The geochemical and MT survey results will inform Dateline’s upcoming drilling campaigns, including a maiden REE-focused drilling program. The company is adopting a “stacked evidence” approach, integrating geochemical, gravity, MT, and potentially magnetic data to optimize drill targeting. Further updates will follow as results are received.
About Dateline Resources Limited
Dateline Resources Limited (ASX: DTR, OTC: DTREF) is an Australian publicly listed company focused on high-value mining and exploration in North America. Its flagship Colosseum Gold-REE Project in California’s Walker Lane Trend combines a proven gold resource with emerging rare earth potential, positioning Dateline as a leader in critical minerals and precious metals.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of applicable securities laws. These statements relate to future events or performance, including the potential of the Colosseum Project, the benefits of U.S. government support, the company’s plans for future development, and the strategic importance of the project for U.S. critical minerals supply. Forward-looking statements are based on current expectations, estimates, and projections and are subject to risks and uncertainties that could cause actual results to differ materially. These risks include fluctuations in gold and rare earth element prices, changes in regulatory or permitting processes, geological or technical challenges, market conditions affecting capital raising, environmental or social factors, and risks related to securing government funding. Dateline Resources cautions readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The company undertakes no obligation to update or revise these statements, except as required by law.
TRNR is expected to have the largest US publicly listed crypto treasury focused on an AI-token
TRNR began acquiring $FET in the open market over the weekend
ATW Partners and DWF Labs invested $55 million in initial closing
AUSTIN, TX / ACCESS Newswire / June 16, 2025 / Interactive Strength Inc. (Nasdaq:TRNR), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today announced that it closed on the initial $55 million investment for its crypto treasury strategy on Friday, June 13th and began acquiring $FET tokens in the open market over the weekend, due to crypto’s 24/7 trading, through its custodian, BitGo.
TRNR will continue to acquire $FET in the open market with the remaining net proceeds of the initial funding, and with any net proceeds from additional fundings from the $500 million facility as they are closed. The $FET purchases from the initial funding are expected to result in TRNR holding the largest publicly listed crypto treasury focused on an AI-token. $FET is a top-50 cryptocurrency and a top-5 AI-focused cryptocurrency by market capitalization according to coinmarketcap.com.
The initial $55 million was invested by private equity firm ATW Partners and crypto market maker DWF Labs.
For more commentary, information and details on the rationale for and structure of the expected acquisition, please see TRNR’s investor website as well as its required filings with the U.S. Securities and Exchange Commission (SEC).
Interactive Strength Inc. produces innovative specialty fitness equipment and digital fitness services under two main brands: 1) CLMBR and 2) FORME. Interactive Strength Inc. is listed on NASDAQ (symbol: TRNR).
CLMBR is a vertical climbing machine that offers an efficient and effective full-body strength and cardio workout. CLMBR’s design is compact and easy to move – making it perfect for commercial or in-home use. With its low impact and ergonomic movement, CLMBR is safe for most ages and levels of ability and can be found at gyms and fitness studios, hotels, and physical therapy facilities, as well as available for consumers at home. www.clmbr.com.
FORME is a digital fitness platform that combines premium smart gyms with live virtual personal training and coaching to deliver an immersive experience and better outcomes for both consumers and trainers. FORME delivers an immersive and dynamic fitness experience through two connected hardware products: 1) The FORME Studio Lift (fitness mirror and cable-based digital resistance) and 2) The FORME Studio (fitness mirror). In addition to the company’s connected fitness hardware products, FORME offers expert personal training and health coaching in different formats and price points through Video On-Demand, Custom Training, and Live 1:1 virtual personal training. www.formelife.com.
Channels for Disclosure of Information In compliance with disclosure obligations under Regulation FD, we announce material information to the public through a variety of means, including filings with the Securities and Exchange Commission (“SEC”), press releases, company blog posts, public conference calls, and webcasts, as well as via our investor relations website. Any updates to the list of disclosure channels through which we may announce information will be posted on the investor relations page on our website. The inclusion of our website address or the address of any third-party sites in this press release are intended as inactive textual references only.
Forward Looking Statements:
This press release includes certain statements that are “forward-looking statements” for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. Forward-looking statements generally are accompanied by words such as “believe”, “project”, “expect”, “anticipate”, “estimate”, “intend”, “strategy”, “future”, “opportunity”, “plan”, “may”, “should”, “will”, “would”, “will be”, “will continue”, “will likely result” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the possibility of acquiring future businesses or completing the referenced pending transactions in a timely manner or at all, the ultimate gross proceeds of the financing, the Company having the largest US publicly listed crypto treasury focused on an AI-token, and the financing strengthening the Company’s financial flexibility, supporting the Company’s AI and digital fitness ambitions, and increasing shareholder exposure to next-generation growth assets. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of the Company. Risks and uncertainties include but are not limited to: whether ATW Partners and / or DWF Labs will invest further amounts, other US publicly listed companies’ crypto strategies, and the price of $FET tokens. A further list and descriptions of these risks, uncertainties and other factors can be found in filings with the Securities and Exchange Commission. To the extent permitted under applicable law, the Company assumes no obligation to update any forward-looking statements.
LONDON, UK AND VANCOUVER, BC / ACCESS Newswire / June 16, 2025 / Mkango Resources Ltd. (AIM:MKA)(TSX-V:MKA) (“Mkango”) and CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec”) are pleased to provide a technical update for HyProMag Limited (“HyProMag”) and its ongoing advanced pilot programme for the scale-up and roll out of Hydrogen Processing of Magnet Scrap (“HPMS”) technology to produce domestically sourced and short-loop recycled rare earth magnets with a minimal carbon footprint in the UK (2025), Germany (2025) and United States (2027).
The ongoing advanced pilot programme at the University of Birmingham is proceeding in parallel with development of the commercial scale plant at Tyseley Energy Park in Birmingham, UK.
HPMS technology was developed by the Magnetic Materials Group at the University of Birmingham (“UoB”), underpinned by approximately US$100 million of research and development funding. HPMS has major competitive advantages over other rare earth magnet recycling technologies, which are largely focused on chemical processes but do not solve the challenges of extracting magnets from end-of-life scrap streams and only produce rare earth oxides or mixed rare earth carbonates, which require further processing. HyProMag provides the solution, producing a value-added, magnet product for direct sale to domestic customers across multiple jurisdictions.
Over the course of the previous 12 months, HyProMag has made significant technical progress to support its efforts in optimising design criteria, processing different NdFeB scrap feed materials and producing recycled, low carbon, commercial, magnets of different technical grades. To date, the University of Birmingham Pilot plant has produced over 3,500 magnets of commercial grade from various waste streams. Sample magnets have been provided to commercial partners for extensive testing and product verification and will support continued off taker due diligence over the coming 12 months for the UK, Germany and U.S. businesses.
Recent progress and technical milestones for HyProMag include the following:
Further optimisation of HPMS for different NdFeB scrap sources – HPMS continues to demonstrate very effective removal and recycling of magnets from electric motor rotors, where they are embedded in laminated stacks of transformer steel. HyProMag is engaging with multiple parties in this sector to provide pre-processing and recycling solutions, as well as in other sectors such as e-bikes, medical devices and professional audio units.
Hard disk drive (HDD) magnets continue to be an important feedstock for HyProMag with HPMS now succesfully demonstrated on at least 18 different morphologies of HDDs and commercial grade N45M and N42M magnets produced from the liberated HPMS powder. These and other magnets produced via HPMS from other scrap sources, ranging in grade from N48 remanence and UH coercivity, are currently being tested in a wide range of applications, including automotive, audio and others.
In collaboration with ZF Automotive and UoB, HyProMag has recently supplied magnets for prototype testing in automotive ancillary applications which were successfully tested by ZF, with performance nearly identical to magnets made from virgin materials as indicated in the recent press article: https://www.engineerlive.com/content/recycling-and-reusing-motor-magnets .
As a key partner in the Securing Critical Rare Earth Materials (“SCREAM”) project, GKN Automotive was instrumental in delivering simulation and physical testing to verify that the HyProMag magnets produced via short-loop recycling have equivalent performance to primary magnets of the same grade.
The first production-ready HDD magnet separation system has been built by INSERMA ANOIA SL (“Inserma”) [i] and is expected to be delivered to the UK in Q3. The system has been shown to more accurately identify and remove the magnets from HDD for HPMS processing at scale. The addition of a printed circuit board removal module is at an advanced stage of development, which would be transformational for the process and enhances the Information Security requirements of HDD Recycling.
Increased magnetic performance has been achieved through further optimisation of the HPMS and magnet manufacturing processes, with positive feedback from customers who are currently stress testing magnet prototypes. Further technical details, including magnet grades and performance achieved, are elaborated in a detailed HyProMag technical bulletin, which can be accessed via the following link: https://hypromag.com/executive-summary-of-recent-technical-progress-by-hypromag-ltd-june-2025
Magnets produced from HPMS generated alloys are the first sintered NdFeB magnets to be produced in the UK since the closure of Philips in Southport in December 2003. This capability for manufacture of sintered, commercial grade magnets need not be confined to producing magnets directly from scrap and can be further enhanced by blending with new cast alloys made from virgin mine-sourced metals or recycled metals.
Acceleration of research and development (R&D) work on blending recycled HPMS powders with virgin materials (from primary as well as medium and long loop recycled sources) is underway, which will broaden the range to higher magnet grades available for commercial purchase and aligns strongly with incoming thresholds for minimum recycled content under the European Union Critical Raw Materials Act.
Over 100 different blends of recycled material have been created in the last six months to meet R&D and customer requirements, with magnets derived from both single and blended batches of HPMS powder demonstrating consistent performance and further validating the short-loop recycling and magnet manufacturing process.
Whether in collaborative projects, such as SusMagPro and REEsilience in Europe and UKRI (United Kingdom Research and Innovation) projects RaRE, REAP, SCREAM, ReREwind and REEmelt, or through other collaborations, HyProMag’s development partners remain confident of its continuing progress. A recent article has been published which has acknowledged the quality of magnets produced for rotating machines:
Through the abovementioned workstreams, together with further optimisation and development of blending and grain boundary technologies, HyProMag expects to significantly expand the range of commercial grades produced as illustrated below:
Will Dawes, Mkango CEO commented: “HyProMag is going from strength to strength with the support of its excellent and growing team, as well as from the University of Birmingham and its other partners. The company is well placed to capitalise on the increasing demand for more robust supply chains and sustainably sourced magnetic materials – technologies being commercialised by HyProMag will be transformational for the sector, and we look forward to first sales in UK and Germany in the coming months, as well as completion of detailed engineering in the USA in advance of large-scale project development.”
Julian Treger, CoTec CEO commented: “ We are very pleased with the continued progress of HyProMag in advance of the commissioning of the UK and German plants. The learnings from these plants and the University of Birmingham’s pilot plant programme represent a significant opportunity for HyProMag USA to optimise and refine the detailed design phase. Furthermore, the production of a wide range of magnet grades for U.S. customers from multiple scrap feedstocks will support our financing and off take activities.”
Nick Mann, HyProMag Limited MD commented: “The improvements on magnetic properties made are down to the increased understanding gained by the metallurgical team on how to process, blend and sinter differing input feed stocks to achieve a consistent grade of magnet. As we begin production at Tyseley we are testing, collaborating and supplying our commercial partners with our magnets against specifications and are demonstrating good alignment with their products.”
Sean Worrall, GKN Automotive Chief Engineer Product Sustainability commented: “As the key physical testing and simulation partner, we are pleased to confirm that the recycled magnets replicated expected performance exceptionally closely during testing. This means HyProMag’s short-cycled magnets can be reliably used in motor design simulation to deliver real world performance. The HPMS process enables a supply chain of sustainable, competitive, rare-earth magnets, decoupled from the problems of the virgin material supply chain”
2025 University of Birmingham (UoB) Accelerated Pilot Programme
In parallel with commissioning of the commercial plants in UK and Germany, and to support ongoing HyProMag USA LLC (“HyProMag USA”) detailed design [ii] , HyProMag has further invested in piloting utilising the UoB infrastructure, onboarded new production engineers and tripled the throughput capacity of the UoB pilot vessel and associated processes. During a six-month period, multiple sources of scrap feeds will be processed with a target of two tonnes of HPMS power produced and converted into commercial grade magnets. HyProMag will provide these samples to potential customers, as well as targeting further improvements in the engineering design criteria, recoveries and magnet making capability to support commercial developments in the UK, Germany and U.S.
The main objectives of the 2025 UoB Accelerated Pilot Programme are to:
Provide NdFeB block and finished magnet samples to customers , to support product marketing, offtake discussions and scale-up in Europe and North America, and to complement HyProMag’s 2025 commercial production of NdFeB alloys, blocks and finished magnets derived from the commercial scale plant being commissioned at Tyseley Energy Park (TEP) by the University of Birmingham.
Enhanced QAQC planning – Commercial production at TEP is targeted at 600kg batches of HPMS powder that will be analysed by ICP-OE, XRF and gas analysis. These characterised batches will be blended for targeted magnet qualities based on the development know-how from piloting. These batches will be large and consistent in quality; 1.2 tonnes of blended powder can, for example, deliver 50,000 magnets based on a typical 25g speaker application. Sampling QAQC procedures are being developed with end-users.
Further demonstrate and optimise HPMS , including pre-processing for larger volumes and broader variety of scrap feeds to derive optimal process conditions and estimates of recovery, NdFeB magnet content and yield to short loop recycling for different scrap feeds
Complete further variability analysis across different HPMS batches of the same type of scrap feed.
Further demonstrate the ability to blend HPMS powders from different HPMS batches of the same scrap feed with or without virgin feed additions
The Accelerated Piloting Programme targets over 50 additional HPMS runs over a six-month period covering principal scrap feeds containing: separated magnet scrap, VCMs from different sources, pre-processed HDD feed, surface mounted and embedded rotors from electric motors, MRI, wind turbine feed, speaker assemblies and other forms of NdFeB scrap material provided by strategic partners.
About Mkango Resources Ltd.
Mkango is listed on the AIM and the TSX-V. Mkango’s corporate strategy is to become a market leader in the production of recycled rare earth magnets, alloys and oxides, through its interest in Maginito Limited (“Maginito”), which is owned 79.4 per cent by Mkango and 20.6 per cent by CoTec, and to develop new sustainable sources of neodymium, praseodymium, dysprosium and terbium to supply accelerating demand from electric vehicles, wind turbines and other clean energy technologies.
Maginito holds a 100 per cent interest in HyProMag and a 90 per cent direct and indirect interest (assuming conversion of Maginito’s convertible loan) in HyProMag GmbH, focused on short loop rare earth magnet recycling in the UK and Germany, respectively, and a 100 per cent interest in Mkango Rare Earths UK Ltd (“Mkango UK”), focused on long loop rare earth magnet recycling in the UK via a chemical route.
Maginito and CoTec are also rolling out HPMS recycling technology into the United States via the 50/50 owned HyProMag USA LLC joint venture company.
Mkango also owns the advanced stage Songwe Hill rare earths project in Malawi (“Songwe”) and the Pulawy rare earths separation project in Poland (“Pulawy”). Both the Songwe and Pulawy projects have been selected as Strategic Projects under the European Union Critical Raw Materials Act. Mkango has signed a letter of Intent with Crown PropTech Acquisitions to list the Songwe Hill and Pulawy rare earths projects on NASDAQ via a SPAC Merger.
For more information, please visit www.mkango.ca
About CoTec Holdings Corp.
CoTec is a publicly traded investment issuer listed on the Toronto Venture Stock Exchange (“TSX- V”) and the OTCQB and trades under the symbols CTH and CTHCF respectively. CoTec Holdings Corp. is a forward-thinking resource extraction company committed to revolutionizing the global metals and minerals industry through innovative, environmentally sustainable technologies and strategic asset acquisitions. With a mission to drive the sector toward a low-carbon future, CoTec employs a dual approach: investing in disruptive mineral extraction technologies that enhance efficiency and sustainability while applying these technologies to undervalued mining assets to unlock their full potential. By focusing on recycling, waste mining, and scalable solutions, the Company accelerates the production of critical minerals, shortens development timelines, and reduces environmental impact. CoTec’s strategic model delivers low capital requirements, rapid revenue generation, and high barriers to entry, positioning it as a leading mid-tier disruptor in the commodities sector.
For more information, please visit www.cotec.ca.
About HyProMag USA LLC.
HyProMag USA is owned 50:50 by CoTec and HyProMag Limited. HyProMag Limited is 100 per cent owned by Maginito, which is owned on a 79.4/20.6 per cent basis by Mkango and CoTec.
For more information, please visit www.hypromagusa.com
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (‘MAR’) which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.
This news release contains forward-looking statements (within the meaning of that term under applicable securities laws) with respect to Mkango and CoTec. Generally, forward looking statements can be identified by the use of words such as “plans”, “expects” or “is expected to”, “scheduled”, “estimates” “intends”, “anticipates”, “believes”, or variations of such words and phrases, or statements that certain actions, events or results “can”, “may”, “could”, “would”, “should”, “might” or “will”, occur or be achieved, or the negative connotations thereof. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. Such factors and risks include, without limiting the foregoing, the delivery and effectiveness of the HDD magnet separation system built by Inserma, the results of the Accelerated Pilot Programme at UoB, the availability of (or delays in obtaining) financing to develop Songwe Hill, the Recycling Plants being developed by Maginito in the UK, Germany and the US (the “Maginito Recycling Plants”), governmental action and other market effects on global demand and pricing for the metals and associated downstream products for which Mkango is exploring, researching and developing, geological, technical and regulatory matters relating to the development of Songwe Hill, the ability to scale the HPMS and chemical recycling technologies to commercial scale, competitors having greater financial capability and effective competing technologies in the recycling and separation business of Maginito and Mkango, availability of scrap supplies for Maginito’s recycling activities, government regulation (including the impact of environmental and other regulations) on and the economics in relation to recycling and the development of the Maginito Recycling Plants, and Pulawy and future investments in the United States pursuant to the proposed cooperation agreement between Maginito and CoTec, cost overruns, complexities in building and operating the plants, and the positive results of feasibility studies on the various proposed aspects of Mkango’s, Maginito’s and CoTec’s activities. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company and CoTec disclaim any intention and assume no obligation to update or revise any forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law. Additionally, the Company and CoTec undertake no obligation to comment on the expectations of, or statements made by, third parties in respect of the matters discussed above.
For further information on Mkango, please contact:
Mkango Resources Limited William Dawes Alexander Lemon Chief Executive Officer President will@mkango.caalex@mkango.ca Canada: +1 403 444 5979 www.mkango.ca @MkangoResources
SP Angel Corporate Finance LLP
Nominated Adviser and Joint Broker Jeff Keating, Jen Clarke, Devik Mehta UK: +44 20 3470 0470
Alternative Resource Capital
Joint Broker Alex Wood, Keith Dowsing UK: +44 20 7186 9004/5
For further information on CoTec, please contract:
The TSX Venture Exchange has neither approved nor disapproved the contents of this press release. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any equity or other securities of the Company in the United States. The securities of the Company will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) and may not be offered or sold within the United States to, or for the account or benefit of, U.S. persons except in certain transactions exempt from the registration requirements of the U.S. Securities Act.
New partnership expands global access to Corsair’s recycled plastic oil across Europe, Asia, and the Americas.
AMSTERDAM, NETHERLANDS / ACCESS Newswire / June 16, 2025 / Plastic waste recycling company Corsair Group International Holding BV (CORSAIR) is proud to announce a new strategic partnership with KERA Energy AG, a Swiss-based leader in sustainable industrial value chains. Under the agreement, CORSAIR will supply advanced pyrolysis oil to KERA Energy, which will distribute the Plastic Pyrolysis Oil (PPO) across key markets in Europe, Asia, and the Americas.
This collaboration marks another important step in CORSAIR’s mission to scale up sustainable advanced recycling of plastic waste. The agreement with KERA Energy signals growing international demand for CORSAIR’s high-quality pyrolysis oil derived from everyday household plastic waste.
“We are very pleased to partner with KERA Energy, a company that shares our vision of a cleaner, circular economy,” said Jussi Veikko Saloranta, CEO of CORSAIR. “KERA’s extensive expertise and market access will allow us to accelerate our environmental impact and expand our reach globally.”
Founded in 1999 and headquartered in Zug, Switzerland, KERA Energy AG specializes in the optimization of supply chains and the commercialization of sustainable raw materials such as plastic pyrolysis oil (PPO) and tire pyrolysis oil (TPO). With a processing capacity of up to 300,000 tons per year and compliance with ISCC+ and REACH regulations, KERA is at the forefront of enabling circular and bio-based feedstock solutions for the chemical and refining industries.
“We are proud to partner with CORSAIR as we jointly work to eliminate plastic waste from our environment,” said Shane Perl, CEO of KERA Energy.
By utilizing CORSAIR’s pyrolysis oil, produced from mixed plastic household waste at facilities in Thailand, Finland and its future facilities, KERA will support the production of new, sustainable plastics and chemicals, reducing dependency on fossil-based virgin feedstocks, diverting plastic waste destined for landfill or incineration and contributing to a closed-loop system for plastic materials.
“We work with pyrolysis companies from concept to technical development and on to commercially optimizing their circular and bio-based oil products.”
Simon Housecraft, Head of Sustainable Materials at KERA, states: “We are committed to building a bridge between environmental goals and industrial performance, and this partnership with CORSAIR embodies that commitment. We believe CORSAIR will remain one of the global leaders within this market sector with ambitious but, realistic expansion plans. As a partnership, we believe we can successfully deliver circularity to our market sector”
With this new alliance, CORSAIR strengthens its role as the fastest growing company in advanced plastic recycling and takes another key step toward a world where waste is transformed into valuable resources for the future.
SOUTHLAKE, TX AND NEW YORK, NY / ACCESS Newswire / June 16, 2025 / Allied OMS, a doctor-led management services organization (MSO) supporting premier oral and maxillofacial surgery practices across the United States, is pleased to announce it has received a significant minority investment from 65 Equity Partners, a global investment firm dedicated to supporting family-owned businesses, founders, and entrepreneurs. Everberg Capital, a private capital investment firm, will also co-invest alongside 65 Equity Partners. This marks the first institutional capital raised by Allied OMS and will enable the firm to further boost its capabilities and service offerings for the benefit of its surgeons and their practices.
Founded in 2020, Allied OMS was created by surgeons, for surgeons, with a clear vision: to develop a unique, doctor-centric model, uniting clinical excellence with strategic business expertise in the oral and maxillofacial surgery field. This approach has proved highly successful, attracting the most well-regarded surgeons practicing across the U.S., with Allied OMS now supporting practices across 50+ locations nationwide.
65 Equity Partners will support Allied OMS’s commitment to long-term value creation, sustainable growth, and expanding patient access to high-quality care. The investment will enable Allied OMS to further enhance its service offerings and capabilities, support complementary acquisitions, and scale operational capabilities.
“When we set out to find an equity partner, we wanted a firm that understood the nuances of our specialty, respected our culture, and shared our vision for building a doctor-centered platform that prioritizes patient care and takes a smart, strategic approach to growth,” said Dan Hosler, Co-Founder and CEO of Allied OMS. “65 Equity Partners stood out for their healthcare expertise, collaborative approach, and long-term perspective, all of which align with our mission to put surgeons’ needs first.”
Leon Brujis, Partner and Head of East Coast at 65 Equity Partners, noted, “Allied OMS represents everything we look for in a platform: a founder-led team with a track record of execution, a recession-resilient sector, and significant white space for value creation.”
“We have been impressed by Allied OMS’s uniquely doctor-led and patient-centric culture, and have strong conviction in the team’s ability to drive disciplined growth,” added Pascal Heberling, Partner and Co-Head of Europe, responsible for Healthcare at 65 Equity Partners.
Much of Allied OMS’s growth has been driven by peer referrals and surgeon-led recruitment, with a robust pipeline of new doctors, partnerships, de novo locations, and clinical initiatives.
“Our expansion has been powered by a network of doctors who are deeply engaged in advancing the platform,” said Dr. David Kostohryz, Co-Founder, Board Director, and Recruiting Committee Chair at Allied OMS. “They play a central role in shaping the direction of the business and work hand-in-hand with our management team to identify needs and implement strategic solutions that enhance practice performance.”
This strong surgeon engagement not only drives growth but also reinforces a culture of clinical excellence across the platform.
“At Allied OMS, we’re fortunate to work with an extraordinary network of surgeons who are not only leaders in their field but also firmly committed to delivering exceptional care,” said Dr. Jonathon Jundt, Co-Founder, Board Director, and Chief Medical Officer at Allied OMS. “To protect that commitment, we’ve built a governance model where surgeons remain firmly at the helm. Our board is majority doctors, each bringing diverse perspectives from different stages of their careers. This ensures that every strategic decision supports, rather than disrupts, our ability to provide medical excellence. With this new partnership, we’re not just preserving that model, we’re expanding it.”
Dr. Greg Scheideman, Co-Founder of Allied OMS, added, “This platform is unique because it was designed with the surgeon’s voice at the very heart of the business. We govern, operate, and grow Allied OMS as owners, and we now welcome investor partners who respect that ethos.”
Allied OMS was advised by BDO, Cain Brothers, KeyBanc Capital Markets, and Miller Johnson. 65 Equity Partners was advised by Jefferies. The transaction was supported by diligence advisors including Aon, Baker McKenzie, Bain & Company, FTI Consulting, Goodwin Procter, PwC, and Scherzer International.
About Allied OMS Allied OMS is a doctor-owned, doctor-led, and doctor-governed MSO that partners with oral and maxillofacial surgery practices across the U.S. Combining the autonomy of private practice with the scale and sophistication of institutional support, Allied OMS empowers surgeons to lead the future of their specialty. The company currently supports surgeons in 50+ locations and maintains doctor leadership across all major committees and its Board of Directors. Learn more at www.alliedoms.com.
About 65 Equity Partners 65 Equity Partners is a global investment firm that partners with founders, families, and entrepreneurs across North America, Europe and Asia to build sustainable, long-term value. We invest in leading businesses across the healthcare, industrial, business services, technology, and consumer sectors.
Backed by Temasek, as an independently managed investment platform with US$3.3 billion in funds under management, we provide equity and structured capital solutions to established companies with regional or global growth ambitions. With offices in Singapore, New York, San Francisco, London and Paris, we leverage our local roots, international network and the deep expertise of our broader ecosystem.
The announcement of the investment in Allied OMS follows the recent international acquisitions of a minority interest in HAS Healthcare Advanced Synthesis SA, a producer of active pharmaceutical ingredients, and simultaneous merger with Cerbios-Pharma SA; the acquisition of a minority interest in Kee Safety, a global leader in safety systems and solutions; the acquisition of a minority stake in Kendra Scott, the celebrated lifestyle and accessories brand, and the acquisition of a minority stake in Felix Storch, a leading provider of specialty refrigeration and cooking appliances.
New Capability Will Transform Airborne Early Warning Access and Affordability for MQ-9B Customers
SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI) is partnering with Saab to develop Airborne Early Warning and Control (AEW&C) capability for its line of MQ-9B Remotely Piloted Aircraft, which includes the SkyGuardian® and SeaGuardian® models, the United Kingdom’s Protector, and the new MQ-9B STOL (Short Takeoff and Landing) model currently in development. GA-ASI plans to fly AEW on MQ-9B in 2026.
“High and low-tech air threats both pose major challenges to global air forces,” said GA-ASI President David R. Alexander. “We’re developing an affordable AEW solution in cooperation with Saab, the leading provider of AEW&C systems, that will transform our customers’ operations against both sophisticated cruise missiles and simple but dangerous drone swarms. We’re also making AEW capability possible in areas it doesn’t exist today, such as from some navy warships at sea.”
GA-ASI will pair Saab’s AEW sensors with the world’s longest-range, highest-endurance unmanned aircraft system (UAS), the MQ-9B. At sea or over land, the AEW mission package on MQ-9B will put air dominance within reach at a lower cost than legacy platforms.
The MQ-9B AEW solution will offer critical aloft sensing to defend against tactical air, guided missiles, drones, and other threats at a fraction of the cost of manned platforms. Operational availability for medium-altitude long-endurance UAS is the highest of any military aircraft, and as an unmanned platform, its aircrew are not put into harm’s way. AEW for MQ-9B will augment existing AEW fleets by extending their effective ranges. It also gives air forces that need AEW, but lack legacy platforms, a powerful and affordable means to counter threats.
GA-ASI and Saab’s AEW offering will span a wide range of applications, including early detection and warning; long-range detection and tracking; simultaneous target tracking and flexible combat system integration, all over line-of-sight and SATCOM connectivity.
MQ-9B is the world’s most advanced medium-altitude, long-endurance UAS. GA-ASI has MQ-9B orders from the United Kingdom, Belgium, Canada, Poland, Japan, Taiwan, India, and the U.S. Air Force in support of the Special Operations Command. MQ-9B has also supported various U.S. Navy exercises, including Northern Edge, Integrated Battle Problem, RIMPAC, and Group Sail.
About GA-ASI
General Atomics Aeronautical Systems, Inc., is the world’s foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 8 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle® 25M, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.
Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.
SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI), the world leader in unmanned aircraft from the iconic Predator® to the YFQ-42A Collaborative Combat Aircraft, has unveiled a new small uncrewed launched effect with widespread multi-mission capabilities for the global aerospace and defense market.
Inspired by Pele, the Hawaiian goddess of powerful natural forces in the Pacific, the Precision Exportable Launched Effect – PELE – is a small, attrition-tolerant, propeller-driven unmanned aircraft designed to extend the sensing and other capabilities of a mothership aircraft and its user service. PELE is a semi-autonomous unmanned aircraft system (UAS) with an 11-foot wingspan and 16-horsepower engine that extends user reach within challenging environments with potent effects. PELE also could be launched from the ground.
The new PELE is optimized for use on the MQ-9B SkyGuardian®, the world’s foremost medium-altitude, long-endurance, multi-mission uncrewed aircraft. MQ-9B is in use or being considered for use by a growing number of nations around the world. PELE can fly with an onboard electro-optical infrared sensor for full-motion video as well as other integral sensors. The aircraft also has internal stowage for its own mission payloads.
“PELE brings even more versatility to growing MQ-9B fleets around the world,” said GA-ASI President David R. Alexander. “On one day, an air force might fly an MQ-9B with no external payloads to maximize its patrol time. Then on the next day, the same aircraft could take off and fly with several PELEs that would stand in against the adversary and take the immediate risks to preserve the larger aircraft.”
For example, MQ-9B might approach a contested boundary from international waters and release PELE to scout through the disputed zone to assess a hostile force’s order of battle or detect and precisely geo-locate anti-air systems. PELE is 9 feet in length, has a maximum gross takeoff weight of 250 pounds, 7 hours of endurance and range of 500 nautical miles.
About GA-ASI
General Atomics Aeronautical Systems, Inc., is the world’s foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 8 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle® 25M, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.
Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.
Planning Underway for Expedited Follow-up RC and Diamond Programs
HIGHLIGHTS
2,882m reverse circulation (RC) drilling completed at Tolmer high-grade silver discovery; recent expansion from 13 to 21 holes based upon early drilling program observations[1]
Program expanded in all directions with two additional lines to north and south
ADELAIDE, AUSTRALIA / ACCESS Newswire / June 15, 2025 / Barton Gold Holdings Limited (ASX:BGD)(FRA:BGD3)(OTCQB:BGDFF) (Barton or Company) is pleased to confirm that expanded RC drilling has completed at its recent ‘Tolmer’ high grade silver discovery, located at the Company’s South Australian Tarcoola Gold Project (Tarcoola).1 A total of 2,882m RC drilling was completed across 21 completed holes to an average depth of 137m. Samples are planned to depart site during the coming week, with the first multi-element assay results expected toward the end of July.
Figure 1 – Tolmer ‘western silver’ & ‘eastern gold’ zones showing expanded silver drilling program
Commenting on the Tolmer drilling program, Barton Managing Director Alexander Scanlon said:
“We look forward to sharing the assay results for this latest round of Tolmer drilling. The western ‘silver zone’ is an exciting target, and we are already planning near-term follow up diamond and RC drilling programs. My thanks to the excellent Barton team, and our drilling partners, for the safe execution of this extended program.”
Program background
Barton identified Tolmer as a high-grade gold discovery in August 2024, and subsequently identified a new ‘silver zone’ ~500m west in a line of seven discovery holes with globally significant assays including:[2]
Hole ID
Interval
Including:
TBAC130
6m @ 4,747 g/t Ag from 46 metres
1m @ 17,600 g/t Ag from 46 metres
TBM227
4m @ 1,417 g/t Ag from 9 metres
1m @ 3,790 g/t Ag from 9 metres
TBM228
14m @ 434 g/t Ag from 46 metres
1m @ 3,350 g/t Ag from 54 metres
On 22 May Barton commenced a planned program of ~2,500m RC drilling which was designed to infill and extend both the western ‘silver zone’ and the eastern ‘gold zone’.[3] Based upon further geological surface reconnaissance and early observations from drilling, it was decided to expand the ‘silver zone’ drilling program to gather a larger amount of data on this area with the remaining time available in this program.[4]
Seven drill holes originally planned for the eastern ‘gold zone’ were re-allocated to eight new drill holes in the western ‘silver zone’, expanding the planned drilling from three to five lines of RC holes. The total Tolmer drilling program was expanded from a planned ~2,500m to a revised final total of 2,882m.
Samples will shortly be despatched for expedited laboratory analysis, with the first multi-element assay results expected to be received toward the end of July. Barton has already commenced planning for follow up programs, including diamond drilling for structural orientation and further extensional RC drilling.
Figure 2 – Tolmer ‘silver zone’ cross-section (see Fig. 2) with anomalous Ag-Pb and key intersections 4
Authorised by the Managing Director of Barton Gold Holdings Limited.
[1] Refer to ASX announcement dated 10 June 2025
[2] Refer to ASX announcements dated 27 August 2024 and 30 January, 6 February, 27 March, 16 April and 22 May 2025
Barton Gold is an ASX, OTCQB and Frankfurt Stock Exchange listed Australian gold developer targeting future gold production of 150,000ozpa with 1.7Moz Au & 3.1Moz Ag JORC Mineral Resources (64.0Mt @ 0.83 g/t Au), brownfield mines, and 100% ownership of the region’s only gold mill in the renowned Gawler Craton of South Australia.
Tarcoola Gold Project
Fully permitted open pit mine with ~20koz Au within trucking distance of Barton’s Central Gawler Mill
Historical goldfield with new high-grade gold-silver discovery in grades up to 83.6 g/t Au and 17,600 g/t Ag
Tunkillia Gold Project
1.6Moz Au & 3.1Moz Ag JORC Mineral Resources
Optimised Scoping Study for competitive ~120kozpa gold and ~250kozpa silver bulk open pit operation
Key Regional Infrastructure
Region’s only gold processing plant (650ktpa CIP)
Multiple camps / accommodation across projects
Competent Persons Statement & Previously Reported Information
The information in this announcement that relates to the historic Exploration Results and Mineral Resources as listed in the table below is based on, and fairly represents, information and supporting documentation prepared by the Competent Person whose name appears in the same row, who is an employee of or independent consultant to the Company and is a Member or Fellow of the Australasian Institute of Mining and Metallurgy (AusIMM), Australian Institute of Geoscientists (AIG) or a Recognised Professional Organisation (RPO). Each person named in the table below has sufficient experience which is relevant to the style of mineralisation and types of deposits under consideration and to the activity which he has undertaken to quality as a Competent Person as defined in the JORC Code 2012 (JORC).
Activity
Competent Person
Membership
Status
Tarcoola Mineral Resource (Stockpiles)
Dr Andrew Fowler (Consultant)
AusIMM
Member
Tarcoola Mineral Resource (Perseverance Mine)
Mr Ian Taylor (Consultant)
AusIMM
Fellow
Tarcoola Exploration Results (until 15 Nov 2021)
Mr Colin Skidmore (Consultant)
AIG
Member
Tarcoola Exploration Results (after 15 Nov 2021)
Mr Marc Twining (Employee)
AusIMM
Member
Tunkillia Exploration Results (until 15 Nov 2021)
Mr Colin Skidmore (Consultant)
AIG
Member
Tunkillia Exploration Results (after 15 Nov 2021)
Mr Marc Twining (Employee)
AusIMM
Member
Tunkillia Mineral Resource
Mr Ian Taylor (Consultant)
AusIMM
Fellow
Challenger Mineral Resource
Mr Dale Sims (Consultant)
AusIMM / AIG
Fellow / Member
The information relating to historic Exploration Results and Mineral Resources in this announcement is extracted from the Company’s Prospectus dated 14 May 2021 or as otherwise noted in this announcement, available from the Company’s website at www.bartongold.com.au or on the ASX website www.asx.com.au. The Company confirms that it is not aware of any new information or data that materially affects the Exploration Results and Mineral Resource information included in previous announcements and, in the case of estimates of Mineral Resources, that all material assumptions and technical parameters underpinning the estimates, and any production targets and forecast financial information derived from the production targets, continue to apply and have not materially changed. The Company confirms that the form and context in which the applicable Competent Persons’ findings are presented have not been materially modified from the previous announcements.
Cautionary Statement Regarding Forward-Looking Information
This document may contain forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “expect”, “target” and “intend” and statements than an event or result “may”, “will”, “should”, “would”, “could”, or “might” occur or be achieved and other similar expressions. Forward-looking information is subject to business, legal and economic risks and uncertainties and other factors that could cause actual results to differ materially from those contained in forward-looking statements. Such factors include, among other things, risks relating to property interests, the global economic climate, commodity prices, sovereign and legal risks, and environmental risks. Forward-looking statements are based upon estimates and opinions at the date the statements are made. Barton undertakes no obligation to update these forward-looking statements for events or circumstances that occur subsequent to such dates or to update or keep current any of the information contained herein. Any estimates or projections as to events that may occur in the future (including projections of revenue, expense, net income and performance) are based upon the best judgment of Barton from information available as of the date of this document. There is no guarantee that any of these estimates or projections will be achieved. Actual results will vary from the projections and such variations may be material. Nothing contained herein is, or shall be relied upon as, a promise or representation as to the past or future. Any reliance placed by the reader on this document, or on any forward-looking statement contained in or referred to in this document will be solely at the readers own risk, and readers are cautioned not to place undue reliance on forward-looking statements due to the inherent uncertainty thereof.
* Refer to Barton Prospectus dated 14 May 2021 and ASX announcement dated 4 March 2025. Total Barton JORC (2012) Mineral Resources include 909koz Au (30.8Mt @ 0.92 g/t Au) in Indicated category and 799koz Au (33.2Mt @ 0.75 g/t Au) in Inferred category, and 3,070koz Ag (34.5Mt @ 2.80 g/t Ag) in Inferred category as a subset of Tunkillia gold JORC (2012) Mineral Resources.
Findings highlight the advantages of Adolore’s approach for the delivery of proprietary gene therapy directly to specialized pain-sensing peripheral nerves (nociceptors) that mediates profound analgesia with the potential to address the great unmet need for non-opioid chronic pain therapies
Data further supports the clinical-translational value of Adolore’s proprietary non-opioid analgesics for treating chronic non-cancer pain
These data support the Company’s continuing efforts to progress with IND-enabling studies of ADB-102 gene therapy for the treatment of osteoarthritis (OA) chronic knee pain.
DELRAY BEACH, FL / ACCESS Newswire / June 15, 2025 / Adolore BioTherapeutics (“Adolore” or the “Company”), a biotechnology company focused on developing breakthrough opioid-free gene therapy treatments for chronic pain and neurological disorders, today announced the publication of its manuscript titled, “Biosafety and Efficacy of Kv7 Activating rdHSV-CA8* Analgesic Gene Therapy for Chronic Pain Via the Intra-Articular Route in Mice1,” in the peer-reviewed journal, Molecular Therapy.
Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, Principal Investigator and Program Director of the NIH, NINDS, HEAL Award supporting ADB-102 development for the treatment of chronic knee pain due to OA, and Founder & Executive Chairman of Adolore BioTherapeutics, published biosafety and efficacy data from preclinical studies of Adolore’s gene therapy expressing a human carbonic anhydrase-8 variant peptide (CA8*). In model systems, replication-defective, disease-free, herpes simplex virus (rdHSV) gene therapy expressing an analgesic carbonic anhydrase-8 (CA8*) peptide variant corrects somatosensory hyperexcitability by activating Kv7 voltage-gated potassium channels, produces profound, long-lasting analgesia and treats chronic pain from knee OA. In these studies, we provide the first non-Good Laboratory Practices (GLP) biosafety, efficacy, biodistribution, shedding, and histopathology examination of this rdHSV-CA8* via the intra-articular knee route of administration. Naive mice were examined for clinical safety, distribution of virus across all major tissues, knee histopathology, and analgesic efficacy. We observed no signs of persistent toxicity or histopathology, viral genomes remained where they were injected, and there was no evidence of shedding. Profound analgesia persisted for >6 months without functional impairments. These initial biosafety and efficacy data support further development of rdHSV-CA8* for treating chronic knee pain due to moderate-to-severe OA.
Dr. Levitt, commented, “Kv7 voltage-gated potassium channel activators, like rdHSV-CA8* open these channels and hyperpolarize nociceptors making them less excitable to produce profound analgesia. Kv7 activators are well-known to produce potent non-opioid-based analgesia in many human chronic pain conditions. While Kv7 openers are no longer available due to off-target adverse events related to systemic administration, they have been successfully translated from animal models to human chronic pain conditions. Bolstered by our substantial body of published data, we continue to develop our innovative approach to address the significant serious unmet need for safe and effective locally acting pain therapies to replace opioids. Our preclinical data strongly support continued preclinical development toward an IND and clinical studies of ADB-102.”
The Company’s lead development program for the treatment of chronic pain in knee osteoarthritis is fully funded by a UG3/UH3 grant awarded to the University of Miami by NIH/NINDS HEAL program to support all formal pre-clinical GLP/GMP/GCP development work through a first-in-human study of ADLR-1l01 in patients expected to commence in 2026.
1 Levitt et al., Biosafety and efficacy of Kv7 activating rdHSV-CA8* analgesic gene therapy for chronic pain via the intraarticular route in mice, Molecular Therapy (2025), https://doi.org/10.1016/j.ymthe.2025.05.02
About Carbonic Anhydrase-8 (CA8*) Gene Therapy
CA8* (variants of naturally occurring human carbonic anhydrase-8 analgesic peptides) gene therapies are a novel class of neuronal calcium channel inhibitors that activate Kv7 voltage-gated potassium channels and are administered locally and long-acting. Oral small molecule pain therapeutics that activate Kv7 voltage-gated potassium channels demonstrated proven analgesic efficacy before they were removed from the market due to severe adverse events related to systemic exposure and their metabolism. CA8* gene therapy provides versatile dosing regimens and routes of administration, including intra-articular, intra-neuronal (nerve block), and intradermal injection. This non-opioid CA8* mechanism-of-action addresses neuropathic, inflammatory, and nociceptive pain, which applies to a broad range of chronic pain indications and neurological disorders. These conditions include osteoarthritis, lower back, and cancer pain; diabetes and other forms of peripheral neuropathy; as well as rare pain conditions such as erythromelalgia, a heritable chronic pain condition and epilepsy and hearing loss.
About Adolore BioTherapeutics, Inc.
Adolore BioTherapeutics, Inc., is a biotechnology company focused on developing novel therapies for treating chronic pain using a revolutionary intra-cellular replication-defective HSV (rdHSV) drug delivery platform that is disease-free, non-toxic, and permits localized peripheral nervous system delivery of proprietary biotherapeutics. This rdHSV gene therapy technology incorporates an established re-dosing strategy and an excellent safety profile. HSV vectors are known for their stability and prolonged gene expression, providing an excellent basis for the long- term treatment of chronic pain conditions and neurological disorders. Our best-in-class CA8* programs are long-acting, locally administered gene therapies that are opioid-free Disease-Modifying Anti-Pain therapies (DMAPs) designed to treat many forms of chronic pain, epilepsy and hearing loss.
Leveraging its innovative gene therapy vectors expressing CA8* analgesic peptides (ADLR-1001), Adolore is currently advancing two preclinical development programs: ADB-101 for the treatment of patients’ chronic pain caused by erythromelalgia, an orphan disease, and ADB-102, their lead program for the treatment of patients with chronic pain caused by knee OA. Based on substantial compelling preclinical data generated to date, the Company is progressing these programs toward IND filings and first-in-human clinical studies. Adolore has two additional programs: ADB-104 for Drug-Resistant Refractory Focal Epilepsy and ADB-105 for Acute Severe Hearing Loss.
To the extent, this announcement contains information and statements that are not historical, they are considered forward-looking statements within the meaning of the federal securities laws. You can identify forward-looking statements by the use of the words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” “will,” “should,” “may,” “plan,” “intend,” “assume” and other expressions which predict or indicate future events and trends and which do not relate to historical matters. You should not rely on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, some of which are beyond the control of the Company. These risks and uncertainties include but are not limited to those associated with drug development. These risks, uncertainties, and other factors may cause the actual results, performance, or achievements of the Company to be materially different from the anticipated future results, performance, or achievements expressed or implied by the forward- looking statements.
New to The Street will continue its coverage with a powerful combination of national TV commercials, long-form interviews, earned media placements, and exposure on iconic outdoor billboards
NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / InterLink Labs, a developer of decentralized identity infrastructure focused on anti-bot solutions in Web3, enhancing real-world verification, asset linking, and smart interactions to reintroduce human connections in the AI is proud to confirm a strategic investment from Google for Startups, reinforcing its position as a vital provider of Web3 infrastructure.
As a client partner of New to The Street, a prominent name in financial media and long-form business broadcasting, InterLink Labs is also proud to announce that it has achieved a milestone of over 1 million AI-driven registered scans through its decentralized identity network. This remarkable achievement occurred within just three months following the launch of its super app, powered by InterLink ID core technology.
Interlink Labs’ AI/Web3 technology enables verifiable ownership of human’s digital ID, digitallinking of real-world and tokenized assets, and next-generation interaction between consumers,enterprises, and smart environments. Its 1 million+ users today can collect Universal BasicIncome (UBI) via the InterLink platform with an AI-powered practical application of InterLink IDto verify a real human participation that can span across luxury goods, events, online gaming, e-learning platforms, healthcare, and verified credentials, each secured by a trustless cryptographic bridge.
“This milestone represents a turning point in how brands and users interact in the Web3 economy, said Vince Caruso, Chief Marketing Officer of Interlink Labs and CEO of New to The Street. “With Google’s investment and our rapid user adoption, Interlink Labs is well-positioned to be the global utility layer for digital-physical verification.”
Interlink Labs’ segment is currently airing on Fox Business and Bloomberg Television as sponsored programming by New to The Street, with broad exposure across national TV, YouTube (2.65M+ subscribers), Times Square digital billboards, and earned media syndication to ABC, NBC, and CBS affiliates.
A new feature on Interlink’s Google-backed technology rollout will premiere this summer as part of New to The Street’s ; Opportunities To Consider™; series, highlighting the transformative role of decentralized scan-based infrastructure in commerce and compliance.
Interlink Labs Inc. is the creator of the anti-bot InterLink Network, a decentralized identity infrastructure powering real-world verification, asset linking, and smart interactions to bring back
the humanity in the age of AI. Its technology enables scan-to-own, scan-to-verify, and scan-to- transact capabilities across industries thus bridging physical and digital trust. For more information, please visit https://interlinklabs.ai/
About New to The Street
Since 2009, New to The Street has combined national TV broadcasts with earned media, iconic outdoor placements, and digital amplification to support innovative public and private companies. With over 220 million weekly TV impressions, 2.65 million YouTube subscribers, and a following of 700,000+ across LinkedIn, Facebook, Instagram, and X, the platform remains the industry standard for predictable, high-impact financial media. For more information, please visit www.newtothestreet.com.
